Guangxi Wuzhou Zhongheng Group Co., Ltd (SHA:600252)

China flag China · Delayed Price · Currency is CNY
2.500
+0.040 (1.63%)
Apr 29, 2026, 3:00 PM CST
Market Cap7.96B +3.9%
Revenue (ttm)1.75B -16.9%
Net Income-357.09M
EPS-0.11
Shares Out3.18B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume34,416,572
Average Volume55,228,865
Open2.460
Previous Close2.460
Day's Range2.440 - 2.510
52-Week Range2.300 - 3.230
Beta0.22
RSI47.01
Earnings DateMar 31, 2026

About SHA:600252

Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology, pediatrics, respiratory, urinary system, and othe... [Read more]

Sector Healthcare
Founded 1993
Employees 2,971
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600252
Full Company Profile

Financial Performance

In 2025, SHA:600252's revenue was 1.75 billion, a decrease of -16.92% compared to the previous year's 2.10 billion. Losses were -357.09 million, -5.28% less than in 2024.

Financial Statements